Cannabis
DGDM Provides Further Analysis of Specific Trial Testing Results of Its Disruptive Pesticide Product Targeted at MJ Growers
Flower Mound, Texas–(Newsfile Corp. – September 10, 2020) – Digital Development Partners, Inc. (OTC PINK: DGDM) (which will become Black Bird Potentials Inc.), exclusive distributor of MiteXstream biopesticide and manufacturer of Grizzly Creek Naturals CBD products, today provided further information relating to the results from ongoing pre-EPA certification in-field, private-party testing of its MiteXstream biopesticide.
In-Field Private Party Testing. We’d, a Montana-licensed Medical Marijuana Dispensary based in Missoula, provides MMJ availability to MMJ cardholders in five Montana cities and has been testing MiteXstream on a designated portion of its cannabis crops over the past year.
No Mites, Mold, Mildew. We’d’s owner, Dylan Matteson, made several observations. “The bottom line is: MiteXstream works extremely effectively. We treated selected plants at each of our grow locations over their entire growth cycle, beginning shortly after sprouting through the day of harvest. We experienced zero spider mites, molds or mildews on the MiteXstream-treated plants, while we did experience spider mites on non-treated plants. However, on the affected plants, a single spray of MiteXstream eliminated them, preventing further propagation.“
Third-Party Lab Test Results. Third-party lab test results for prohibited pesticides on cannabis treated exclusively with MiteXstream are included in DGDM’s most recent Form 10-K filed with the SEC and can be viewed beginning at page 10 of the following link:
https://www.sec.gov/Archives/edgar/data/1409999/000110465920083473/tm205386-1_10k.htm
From now until the anticipated December 2020 EPA approval, the company intends to solidify its distribution strategy.
“I continue to tell everyone, we believe that MiteXstream will prove to be the game changer we thought it would be from the moment we developed it,” said Fabian Deneault, DGDM’s President.
Eradication + Human Safety. MiteXstream destroys spider mites and, importantly, the eggs, almost on contact. And the MiteXstream “super power” is: it can be applied directly to crops through the day of harvest on marijuana and satisfy all marijuana state testing standards, including Oregon, at zero parts per million.
MiteXstream’s efficacy can be seen in this short video:
[youtube https://www.youtube.com/watch?v=pfI5ms9lnMw]
Cannot view this video? Visit:
https://www.youtube.com/watch?v=pfI5ms9lnMw
DGDM: Doing Good, Doing More. By developing and bringing to market an extremely safe, yet highly efficacious alternative to traditional pesticides, MiteXstream is an example of how the company is living up to its mission statement, Doing Good, Doing More.
About DGDM:
Through its subsidiary Black Bird Potentials, DGDM manufactures and sells CBD products, including CBD Oils, gummies and pet treats, and CBD-infused personal care products, as well as hand sanitizer gel and spray products. In addition, Black Bird is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. Black Bird is the exclusive distributor in the U. S. and Canada for MiteXstream, a plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee and house plants, as well as molds and mildew. EPA approval of MiteXstream is expected in late 2020.
Notice Regarding Forward-Looking Statements
This news release contains forward-looking information including statements that include the words “believes,” “expects,” “anticipate,” or similar expressions. Such forward looking-statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof. Information concerning these and other factors can be found in the company’s filings with the SEC, including its Forms 10-K, 10-Q, and 8-K, which can be obtained on the SEC’s website at http://www.sec.gov.
Contact:
Eric Newlan
Vice President
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/63555
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis7 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis6 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan5 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis2 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa